Your browser doesn't support javascript.
loading
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA Trial.
Basile, Debora; Rosati, Gerardo; Bergamo, Francesca; Garattini, Silvio Ken; Banzi, Maria; Zampino, Maria; Bozzarelli, Silvia; Marchetti, Paolo; Galli, Fabio; Galli, Francesca; Longarini, Raffaella; Zaniboni, Alberto; Ferrari, Daris; De Placido, Sabino; Frassineti, Luca Giovanni; Nicolini, Mario; Cinieri, Saverio; Priscindiaro, Michele; Ziranu, Pina; Caccialanza, Riccardo; Pastorino, Alessandro; Mosconi, Stefania; Aprile, Giuseppe.
Affiliation
  • Basile D; Department of Medical Oncology, San Bortolo General Hospital, Vicenza, Italy.
  • Rosati G; Medical Oncology Unit, San Carlo Hospital, Potenza, Italy.
  • Bergamo F; Medical Oncology Unit 1, Istituto Oncologico Veneto-IOV IRCCS, Padova, Italy.
  • Garattini SK; Medical Oncology Unit, Azienda Ospedaliero Universitaria Santa Maria della Misericordia, Udine, Italy.
  • Banzi M; Medical Oncology Unit, AUSL-IRCCS, Reggio Emilia, Italy.
  • Zampino M; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, Istituto Europeo di Oncologia-IRCCS, Milano, Italy.
  • Bozzarelli S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
  • Marchetti P; Medical Oncology Unit Sant'Andrea Hospital, Sapienza University of Rome and IRCCS Istituto Dermopatico dell'Immacolata, Rome, Italy.
  • Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Galli F; Methodology for Clinical Research Laboratory, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Longarini R; Medical Oncology Unit San Gerardo Hospital, Monza, Italy.
  • Zaniboni A; Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy.
  • Ferrari D; Medical Oncology Unit, Azienda Ospedaliera San Paolo, Milano, Italy.
  • De Placido S; Medical Oncology Unit Università Federico II, Napoli, Italy.
  • Frassineti LG; Medical Oncology Unit IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FO), Italy.
  • Nicolini M; Medical Oncology Unit Azienda USL Romagna, Cattolica, Rimini, Italy.
  • Cinieri S; Medical Oncology Unit Ospedale Antonio Perrino, Brindisi, Italy.
  • Priscindiaro M; Medical Oncology Unit1, Fondazione Istituto Nazionale Tumori-IRCCS, Milano, Italy.
  • Ziranu P; Medical Oncology, University Hospital and University of Cagliari, Cagliari, Italy.
  • Caccialanza R; Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Pastorino A; Medical Oncology Unit, IRCCS San Martino-IST-Genova, Genova, Italy.
  • Mosconi S; Cancer Center ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Aprile G; Department of Medical Oncology, San Bortolo General Hospital, Vicenza, Italy. Electronic address: giuseppe.aprile@aulss8.veneto.it.
Clin Colorectal Cancer ; 22(2): 190-198, 2023 06.
Article in En | MEDLINE | ID: mdl-36935327
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Colorectal Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Type: Article Affiliation country: Italy